Primary Ovarian Insufficiency Withdrawn Phase 3 Trials for Medroxyprogesterone acetate (DB00603)

Also known as: Ovarian Insufficiency, Primary / Female hypergonadotropic hypogonadism / Premature ovarian failure / Primary ovarian failure / Ovarian failure primary

IndicationStatusPhase
DBCOND0000990 (Primary Ovarian Insufficiency)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02922348Hormone Replacement for Premature Ovarian InsufficiencyTreatment